Filing Details

Accession Number:
0000899243-16-022949
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-15 17:00:22
Reporting Period:
2016-06-13
Filing Date:
2016-06-15
Accepted Time:
2016-06-15 17:00:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583648 Pieris Pharmaceuticals Inc. PIRS Services-Commercial Physical & Biological Research (8731) 300784346
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645577 S. Stephen Yoder C/O Pieris Pharmaceuticals, Inc.
255 State Street, 9Th Floor
Boston MA 02109
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-13 6,000 $1.68 6,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.680 to $1.687, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.